TCL Archive DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs December 4, 1992
TCL Archive In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires September 9, 1994
TCL Archive FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.” October 21, 2005
